Adjuvant therapy for HER2 positive pT1a-b pN0 breast cancer: A single center cohort study.

Medicine (Baltimore) · 2022 · PMC9276464 · PMID 35758368

Europe PMC DOI

hedged sentence

0.1410

closest p · 2.8× alpha

0.1410

boldest claim

The sentences

did not reach statistical significanceP = .141not close (p > 0.1)

Among patients receiving AST only, the IDFS difference compared with untreated patients did not reach statistical significance ( P = .141, Fig. 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.